Venture Planning Group: Market Research Reports

Publications found: 60,074

Sort by:

2022 Middle East Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database for 11 Countries: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

US$ 7,500.00

This database from LeadingMarketResearch.com provides the 2021 supplier shares, the 2021-2026 volume and sales forecasts for over 40 tests, as well as comprehensive lists of companies developing or ma...

June 2022 -

2022 Moldova Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

US$ 1,450.00

June 2022 -

2022 Myanmar Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

US$ 1,450.00

June 2022 -

2022 Netherlands Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

US$ 1,450.00

June 2022 -

2022 New Zealand Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

US$ 1,450.00

June 2022 -

2022 Nicaragua Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

US$ 1,450.00

June 2022 -

2022 North America Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database for the US, Canada and Mexico: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

US$ 7,500.00

June 2022 -

2022 Norway Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

US$ 1,450.00

June 2022 -

2022 Oman Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

US$ 1,450.00

June 2022 -

2022 Pakistan Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

US$ 1,450.00

June 2022 -

2022 Panama Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

US$ 1,450.00

June 2022 -

2022 Paraguay Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

US$ 1,450.00

June 2022 -

2022 Peru Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

US$ 1,450.00

June 2022 -

2022 Philippines Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

US$ 1,450.00

June 2022 -

2022 Poland Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

US$ 1,450.00

June 2022 -

2022 Portugal Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

US$ 1,450.00

June 2022 -

2022 Puerto Rico Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

US$ 1,450.00

June 2022 -

2022 Qatar Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

US$ 1,450.00

June 2022 -

2022 Romania Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

US$ 1,450.00

June 2022 -

2022 Russia Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

US$ 1,450.00

June 2022 -

2022 Saudi Arabia Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

US$ 1,450.00

June 2022 -

2022 Serbia Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

US$ 1,450.00

June 2022 -

2022 Singapore Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

US$ 1,450.00

June 2022 -

2022 Slovakia Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

US$ 1,450.00

June 2022 -

2022 Slovenia Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

US$ 1,450.00

June 2022 -

2022 South Korea Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

US$ 1,450.00

June 2022 -

2022 Spain Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

US$ 2,500.00

June 2022 -

2022 Sweden Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

US$ 1,450.00

June 2022 -

2022 Switzerland Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

US$ 1,450.00

June 2022 -

2022 Taiwan Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

US$ 1,450.00

June 2022 -

2022 Thailand Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

US$ 1,450.00

June 2022 -

2022 Turkey Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

US$ 1,450.00

June 2022 -

2022 UK Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

US$ 2,500.00

June 2022 -

2022 Ukraine Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

US$ 1,450.00

June 2022 -

2022 United Arab Emirates Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

US$ 1,450.00

June 2022 -

2022 Uruguay Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

US$ 1,450.00

June 2022 -

2022 US Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

US$ 2,500.00

June 2022 -

2022 Venezuela Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

US$ 1,450.00

June 2022 -

2022 Vietnam Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

US$ 1,450.00

June 2022 -

2022 World Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Database for 90 Countries: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests

US$ 27,500.00

June 2022 -

2022-2026 Albania Diagnostics Market: Supplier Shares, Strategies, and Forecasts for 500 Tests-Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

US$ 4,500.00

This new report from LeadingMarketResearch.com provides granular analysis of the diagnostic testing market, including 2021 supplier shares, strategies, as well as 2021-2026 volume and sales forecasts...

June 2022 -